Literature DB >> 15448572

Spasticity: the misunderstood part of the upper motor neuron syndrome.

Cindy B Ivanhoe1, Timothy A Reistetter.   

Abstract

Spasticity is a sensorimotor phenomenon related to the integration of the nervous system motor responses to sensory input. Although most commonly considered a velocity-dependent increase to tonic stretch, it is related to hypersensitivity of the reflex arc and changes that occur within the central nervous system, most notably, the spinal cord. Injury to the central nervous system results in loss of descending inhibition, allowing for the clinical manifestation of abnormal impulses. Muscle activity becomes overactive. This is mediated at several areas of the stretch-reflex pathway. Although spasticity is part of the upper motor neuron syndrome, it is frequently tied to the other presentations of the said syndrome. Contracture, hypertonia, weakness, and movement disorders can all coexist as a result of the upper motor neuron syndrome. Although basic science descriptions of spasticity are being elucidated, clinically, confusion exists.

Entities:  

Mesh:

Year:  2004        PMID: 15448572     DOI: 10.1097/01.phm.0000141125.28611.3e

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  23 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  The impact of early spasticity on the intensive functional rehabilitation phase and community reintegration following traumatic spinal cord injury.

Authors:  Andréane Richard-Denis; Bich-Han Nguyen; Jean-Marc Mac-Thiong
Journal:  J Spinal Cord Med       Date:  2018-12-03       Impact factor: 1.985

3.  Goals Set by Patients Using the ICF Model before Receiving Botulinum Injections and Their Relation to Spasticity Distribution.

Authors:  Kevin Choi; Jaclyn Peters; Andrew Tri; Elizabeth Chapman; Ayako Sasaki; Farooq Ismail; Chris Boulias; Shannon Reid; Chetan P Phadke
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

4.  In Support of Initial Parenteral Medical Management of Intrathecal Baclofen Withdrawal in Spasticity Patients.

Authors:  Brian L LaRowe; Vicki M Nussbaum
Journal:  J Pharm Technol       Date:  2021-08-12

5.  Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

Authors:  G Pryce; D Baker
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

6.  Complications of intrathecal baclofen pump: prevention and cure.

Authors:  Yasser Awaad; Tamer Rizk; Iram Siddiqui; Norbert Roosen; Kelly McIntosh; G Michael Waines
Journal:  ISRN Neurol       Date:  2012-03-24

Review 7.  Motor neurons and the generation of spinal motor neuron diversity.

Authors:  Nicolas Stifani
Journal:  Front Cell Neurosci       Date:  2014-10-09       Impact factor: 5.505

8.  Transcriptional abnormalities of hamstring muscle contractures in children with cerebral palsy.

Authors:  Lucas R Smith; Henry G Chambers; Shankar Subramaniam; Richard L Lieber
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

9.  Elbow spasticity during passive stretch-reflex: clinical evaluation using a wearable sensor system.

Authors:  Chris A McGibbon; Andrew Sexton; Melony Jones; Colleen O'Connell
Journal:  J Neuroeng Rehabil       Date:  2013-06-19       Impact factor: 4.262

10.  Spasticity as the first manifestation of ischaemic lesions involving the cingulum.

Authors:  Ivânia Alves; Vítor Tedim Cruz; Hans Peter Grebe
Journal:  Case Rep Neurol Med       Date:  2013-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.